
Sign up to save your podcasts
Or


She describes Bicara's data in HPV-negative HNSCC, and explains why the company is focused on this HVP-negative population specifically. Plus, how she believes the data compares to a closely watched competitor has a EGFR x LGR5 program.
By BiotechTV4.3
66 ratings
She describes Bicara's data in HPV-negative HNSCC, and explains why the company is focused on this HVP-negative population specifically. Plus, how she believes the data compares to a closely watched competitor has a EGFR x LGR5 program.

3,223 Listeners

1,902 Listeners

124 Listeners

324 Listeners

61 Listeners

9,960 Listeners

86 Listeners

34 Listeners

353 Listeners

19 Listeners

60 Listeners

514 Listeners

41 Listeners

0 Listeners

4 Listeners

2 Listeners

6 Listeners

46 Listeners